Please assess the completion status of the following clinical trial:

Trial Title: Pilot Clinical Evaluation of Dozee VS, a Contactless Continuous Vital Parameters Monitoring System in Hospital Patients

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~1. Adults Male or female. (Above 18 years of age)~2. Provide written informed consent.~3. Weight between 40kg/88.18lbs and 120kg/264.55lbs(Above 40 kgs)~4. Are located in a non-ICU hospital setting.~5. Agree to not eat during the testing period (2hours or 10 hours accordingly)~Exclusion Criteria:~1. Are connected to a device which may interfere with the device monitoring in this study.~2. Are receiving any bedside care which may be incompatible with the study procedures.~3. A likely need to receive or undergo a procedure during the testing period.~4. Cannot accept a nasal cannula, or have a monitor lead placed on the chest.~5. Have a significant medical condition in the judgement of the investigator, which may compromise the study testing procedures.~6. Prisoners

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 100 Years
- Healthy Volunteers: f

Study Arms:
- Single Arm Study (Cohort) (Type: None): All participants will be on standard telemetry monitoring for Heart Rate and Respiration Rate using the gold standard (Electrocardiography and Capnography respectively).~In addition, two contactless monitoring devices will be placed on the patient bed to measure data simulataneously. These devices include EarlySense (USFDA approved ballistocardiography device) and Dozee VS (Investigational Device).

Based on this trial design, predict the completion outcome and termination type (if applicable).